Expertise in
10
conditions

Dr. Manal F. Abdelmalek

Gastroenterology
Private Diagnostic Clinic PLLC
40 Duke Medicine Cir, 
Durham, NC 
Accepting New Patients
Offers Telehealth
28 Years of Experience
Expertise in
10
conditions
Private Diagnostic Clinic PLLC
40 Duke Medicine Cir, 
Durham, NC 

Overview

Manal Abdelmalek is a Gastroenterologist practicing medicine in Durham, North Carolina. She has been practicing medicine for over 28 years.

Dr. Abdelmalek is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Cirrhosis, Enlarged Liver, and Liver Transplant.

She is actively involved in clinical research, co-authoring 161 peer reviewed articles and participating in 15 clinical trials. Dr. Abdelmalek is currently accepting new patients.

Specialties

Gastroenterology

Licenses

Internal Medicine in NC

Hospital Affiliations

Mayo Clinic Hospital Rochester

Languages Spoken

English
Arabic

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
South Country Health Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Private Diagnostic Clinic PLLC
40 Duke Medicine Cir, Durham, NC 27710

Additional Areas of Focus

Dr. Abdelmalek has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

15 Clinical Trials

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) Treatment for 12 Months in Subjects With Biopsy Confirmed NASH
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) Treatment for 12 Months in Subjects With Biopsy Confirmed NASH
Enrollment Status: Completed
Publish Date: August 19, 2026
Intervention Type: Drug
Study Drug: HM15211
Study Phase: Phase 2
Role of Lisinopril in Preventing The Progression of Non-Alcoholic Fatty Liver Disease (NAFLD): Relief-NAFLD
Role of Lisinopril in Preventing The Progression of Non-Alcoholic Fatty Liver Disease (NAFLD): Relief-NAFLD
Enrollment Status: Active_not_recruiting
Publish Date: August 14, 2026
Intervention Type: Drug, Procedure, Other
Study Drug: Lisinopril
Study Phase: Phase 2
Vitamin E Dosing Study (VEDS): A Dose Finding Study of Vitamin E for the Treatment of Adult NAFLD
Vitamin E Dosing Study (VEDS): A Dose Finding Study of Vitamin E for the Treatment of Adult NAFLD
Enrollment Status: Completed
Publish Date: May 14, 2026
Intervention Type: Drug
Study Drug: Vitamin E
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Statins in Adult Patients With Non-Alcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Statins in Adult Patients With Non-Alcoholic Steatohepatitis (NASH)
Enrollment Status: Active_not_recruiting
Publish Date: January 20, 2026
Intervention Type: Drug
Study Drug: Atorvastatin
Study Phase: Phase 2
Nonalcoholic Fatty Liver Disease (NAFLD) Database 3
Nonalcoholic Fatty Liver Disease (NAFLD) Database 3
Enrollment Status: Completed
Publish Date: August 13, 2025
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
Clinical Study of the BreathID® LF System to Train the Algorithm for the ¹³C-Methacetin Breath Test (MBT) in Assessment of Portal Hypertension in Patients With Compensated Liver Cirrhosis
Clinical Study of the BreathID® LF System to Train the Algorithm for the ¹³C-Methacetin Breath Test (MBT) in Assessment of Portal Hypertension in Patients With Compensated Liver Cirrhosis
Enrollment Status: Completed
Publish Date: December 20, 2022
Intervention Type: Device
Study Phase: Not Applicable
Impact of Fructose on Metabolism, Energy Homeostasis and Magnetic Resonance (MR) Biomarkers in Nonalcoholic Fatty Liver Disease (NAFLD)
Impact of Fructose on Metabolism, Energy Homeostasis and Magnetic Resonance (MR) Biomarkers in Nonalcoholic Fatty Liver Disease (NAFLD)
Enrollment Status: Terminated
Publish Date: August 31, 2022
Intervention Type: Other, Drug
Study Drug: Intravenous fructose challenge
Study Phase: Phase 2
Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2
Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2
Enrollment Status: Completed
Publish Date: February 23, 2022
View 9 Less Clinical Trials

161 Total Publications

Currently Approved and Future Regimens for Metabolic Dysfunction-Associated Steatohepatitis.
Currently Approved and Future Regimens for Metabolic Dysfunction-Associated Steatohepatitis.
Journal: Clinics in liver disease
Published: May 16, 2026
Similar Doctors
Expertise in
18
conditions
Dr. Evan S. Dellon
Gastroenterology
Expertise in
18
conditions
Dr. Evan S. Dellon
Gastroenterology
Referral may be required

UNC Hospitals Pulmonary Function Lab

101 Manning Dr, 
Chapel Hill, NC 
 (9.5 miles away)
919-966-5787
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Evan Dellon is a Gastroenterologist practicing medicine in Chapel Hill, North Carolina. Dr. Dellon is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Eosinophilic Esophagitis, Esophagitis, Eosinophilic Enteropathy, Endoscopy, and Colonoscopy. Dr. Dellon is currently accepting new patients.

Expertise in
15
conditions
Dr. Nicholas J. Shaheen
Gastroenterology
Expertise in
15
conditions
Dr. Nicholas J. Shaheen
Gastroenterology
Referral may be required

UNC Hospitals Pulmonary Function Lab

101 Manning Dr, 
Chapel Hill, NC 
 (9.5 miles away)
984-974-5050
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Nicholas Shaheen is a Gastroenterologist practicing medicine in Chapel Hill, North Carolina. Dr. Shaheen is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Barrett Esophagus, Esophagitis, Gastroesophageal Reflux Disease (GERD), Endoscopy, and Tissue Biopsy. Dr. Shaheen is currently accepting new patients.

Expertise in
34
conditions
Dr. Todd H. Baron
Gastroenterology
Expertise in
34
conditions
Dr. Todd H. Baron
Gastroenterology
Referral may be required

Office

130 Mason Farm Rd, 
Chapel Hill, NC 
 (9.7 miles away)
984-974-0132
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Todd Baron is a Gastroenterologist practicing medicine in Chapel Hill, North Carolina. Dr. Baron is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Bile Duct Obstruction, Cholestasis, Cholecystitis, Endoscopy, and Gastrostomy. Dr. Baron is currently accepting new patients.

Frequently Asked Questions about Dr. Manal F. Abdelmalek

How do I make an appointment with Dr. Manal F. Abdelmalek?

You can book an appointment with Dr. Manal F. Abdelmalek by calling their office at 919-684-1817. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Manal F. Abdelmalek a top-rated expert for Non-Alcoholic Fatty Liver Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Manal F. Abdelmalek is classified as an Elite expert for Non-Alcoholic Fatty Liver Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Manal F. Abdelmalek specialize in?

While Dr. Manal F. Abdelmalek is a Gastroenterology, they have specific expertise in Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), and Cirrhosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Manal F. Abdelmalek participate in research or clinical trials?

Yes. Dr. Manal F. Abdelmalek has published 161 articles and abstracts on conditions like Non-Alcoholic Fatty Liver Disease. You can view a list of Dr. Manal F. Abdelmalek's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Manal F. Abdelmalek accept my insurance?

Dr. Manal F. Abdelmalek accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 919-684-1817 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Abdelmalek's expertise for a condition
ConditionClose
View All 19 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile